logo
Atlas Salt Secures $1,000,000 in ACOA Funding for Low Emission Mine Design & Optimization Initiative for Great Atlantic Salt Project

Atlas Salt Secures $1,000,000 in ACOA Funding for Low Emission Mine Design & Optimization Initiative for Great Atlantic Salt Project

ST JOHN'S, NL / ACCESS Newswire / February 5, 2025 / Atlas Salt Inc. ('Atlas Salt' or the 'Company') (TSXV:SALT)(OTCQB:REMRF) is pleased to announce that it has secured a C$1,000,000 conditionally repayable loan from the Atlantic Canada Opportunities Agency (ACOA) under the Regional Economic Growth through Innovation (REGI) program. The funding will support the Company's innovative Mine Design and Optimization Initiative, which focuses on reducing greenhouse gas (GHG) emissions and implementing sustainable mining technologies at the Great Atlantic Salt Project.
ACOA Funding for Low GHG Mine Design Program
In a further step towards the development of the Great Atlantic Salt Project, the Company has secured a C$1,000,000 conditionally repayable loan from the Atlantic Canada Opportunities Agency (ACOA) under the Regional Economic Growth through Innovation (REGI) program. This funding will advance the low GHG Mine Design and Optimization Program, focusing on battery electric vehicles, mine optimization and conducting geotechnical and hydrological studies to support future construction.
The initiative is a key part of the Great Atlantic Salt Project, an underground salt mine being developed on the west coast of Newfoundland and Labrador. Once operational, it will be the first major salt producer to launch in Eastern North America in decades and is expected to create up to 300 full-time construction jobs and 170 permanent positions during operations.
Key details of the ACOA loan include:
This funding from ACOA aligns with Canada's commitment to fostering sustainable economic growth and resource development in Atlantic Canada. By advancing next-generation mining solutions, Atlas Salt is contributing to the region's long-term prosperity and environmental leadership.
Richard LaBelle, CEO of Atlas Salt, commented: 'This initiative is not just about innovation, it's about building a stronger, more sustainable future for Newfoundland and Labrador. By integrating advanced automation and low-emission mining technologies, we are creating new economic opportunities while minimizing environmental impact. Thanks to ACOA's support, the Great Atlantic Salt Project is moving one step closer to becoming a world-class operation that will benefit our province for generations.'
The Honourable Gudie Hutchings, Minister of Rural Economic Development and Minister responsible for ACOA, said: 'This investment from your federal government is about helping Atlas Salt find new ways to boost our economy here in Newfoundland and Labrador. Mining has been part of our history for generations; embracing new technologies, we are setting the stage for an even brighter future right here at home.'
For further information and ongoing updates, please visit https://atlassalt.com.
About Atlas Salt Inc.
Atlas Salt Inc. is developing Canada's next salt mine and is committed to responsible and sustainable mining practices. With a focus on innovation and efficiency, the company is poised to make significant contributions to the North American salt market while upholding its values of environmental stewardship and community engagement.
For information, please contact:
Richard LaBelle, CEO
(709) 739-9545
We seek safe harbor.
Cautionary Statement
Neither the TSX Venture Exchange nor its Regulation Services Provider, (as the term is defined in the Policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. This press release includes certain 'forward-looking information' and 'forward-looking statements' (collectively 'forward-looking statements') within the meaning of applicable Canadian securities legislation. All statements, other than statements of historical fact, included herein, without limitation, statements relating to the future operating or financial performance of the Company, are forward-looking statements. Forward-looking statements are frequently, but not always, identified by words such as 'expects', 'anticipates', 'believes', 'intends', 'estimates', 'potential', 'possible', and similar expressions, or statements that events, conditions, or results 'will', 'may', 'could', or 'should' occur or be achieved. Forward-looking statements in this press release relate to, among other things: obtaining financing, completion, delivery and timing of project components and requirements, and analysis and assumptions related thereto. Actual future results may differ materially. There can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements. Forward-looking statements reflect the beliefs, opinions and projections on the date the statements are made and are based upon a number of assumptions and estimates that, while considered reasonable by the respective parties, are inherently subject to significant business, technical, economic, and competitive uncertainties and contingencies. Many factors, both known and unknown, could cause actual results, performance or achievements to be materially different from the results, performance or achievements that are or may be expressed or implied by such forward-looking statements and the parties have made assumptions and estimates based on or related to many of these factors. Such factors include, without limitation: the timing, completion and delivery of required permits, supply arrangements and financing. Readers should not place undue reliance on the forward-looking statements and information contained in this news release concerning these times. Except as required by law, the Company does not assume any obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Edgewater Wireless Captures Industry Attention at the 2025 Silicon Catalyst Portfolio Update in Silicon Valley
Edgewater Wireless Captures Industry Attention at the 2025 Silicon Catalyst Portfolio Update in Silicon Valley

Business Wire

time32 minutes ago

  • Business Wire

Edgewater Wireless Captures Industry Attention at the 2025 Silicon Catalyst Portfolio Update in Silicon Valley

OTTAWA, Ontario & SANTA CLARA, Calif.--(BUSINESS WIRE)--Edgewater Wireless Systems Inc. (TSXV: YFI) (OTC: KPIFF), the industry pioneer in Wi-Fi Spectrum Slicing for high-density residential and enterprise environments, is excited to share key highlights from the 2025 Silicon Catalyst Portfolio Company Update sessions, held in the heart of Silicon Valley. The invitation-only event brought together over 450 of the semiconductor industry's most influential stakeholders—including strategic advisors, corporate partners, investors, and top-tier venture capitalists—creating a dynamic platform for insight, collaboration, and innovation. Edgewater Wireless made a powerful impression at the 2025 Silicon Catalyst Portfolio Update in Silicon Valley, earning strong interest from global semiconductor leaders. Share 'Our participation in the Silicon Catalyst event was a powerful validation of the industry need for differentiated, high-performance Wi-Fi solutions,' said Andrew Skafel, CEO of Edgewater Wireless. 'The level of engagement we saw—from industry veterans to potential partners and acquirers—demonstrates the growing relevance of Spectrum Slicing in solving today's real-world connectivity challenges.' Edgewater's formal introduction to the Silicon Catalyst community marked a pivotal moment in the company's growth trajectory. During the Portfolio Update and CEO Colloquia sessions, CEO Andrew Skafel delivered a compelling presentation showcasing the company's patented Spectrum Slicing technology and its potential to dramatically improve performance, reliability, and efficiency in increasingly crowded Wi-Fi environments. The presentation drew an enthusiastic response from the packed audience, igniting a lively Q&A session and generating strong follow-up interest from several strategic advisors and corporate strategics. 'Silicon Catalyst's Portfolio Company Update has grown to be a large and influential gathering of the deep-tech hardware industry, especially on the strength of the participation of innovative companies like Edgewater Wireless,' said Nick Kepler, COO of Silicon Catalyst. 'Edgewater's standards-compatible spectrum slicing Wi-Fi technology is committed to dramatically reduce the congestion that plagues modern Wi-Fi, Silicon Catalyst is thrilled to provide a platform to allow Edgewater Wireless to engage with our ecosystem to accelerate the adoption of their technology.' The event also provided Edgewater with valuable opportunities to deepen relationships across the broader semiconductor ecosystem, including key in-kind partners, chip vendors, and platform enablers. Notably, Edgewater was pleased to welcome a key industry research and innovation partner to the session and extend appreciation for their continued interest and participation. With continued traction in enterprise and industrial IoT pilot deployments, growing alignment with silicon ecosystem players, and expanding conversations with potential strategic collaborators, Edgewater is well-positioned to accelerate its commercial roadmap. As always, the company remains committed to keeping investors, customers, and partners informed and engaged as this next phase of growth unfolds. See the recent Silicon Catalyst press release here: The Silicon Catalyst presentation built on the successful participation in two other recent events: RDK Tech Summit 2025 ( Edgewater Wireless was honoured to participate in the exclusive, invitation-only RDK Tech Summit 2025, held May 6–7 at the Hilton London Syon Park. The event brought together a trusted ecosystem of technology vendors, manufacturing partners, and silicon providers that support leading global operators, including Liberty Global, Comcast, and Sky. It was an ideal platform for Edgewater to showcase our Wi-Fi Spectrum Slicing innovations, which significantly enhance performance and reliability in the connected home. Our conversations with key ecosystem partners reaffirmed the growing demand for differentiated Wi-Fi solutions within the industry. They highlighted the opportunity for Edgewater to contribute to the next generation of broadband experiences. CHIPS North Executive Summit ( Edgewater Wireless was proud to participate in the CHIPS North Executive Summit, a premier event spotlighting Canada's rapidly expanding semiconductor ecosystem. The summit provided a valuable platform to showcase our Wi-Fi Spectrum Slicing innovations while connecting with industry leaders, federal government stakeholders, and potential collaborators. A highlight of the event was the presentation by Tarun Verma, Managing Partner at Silicon Catalyst—an Edgewater backer—who offered compelling insights on accelerating semiconductor innovation through strategic incubation. His participation reinforced the strength of our partnership and the ecosystem's growing support for emerging technologies. The summit also emphasized Canada's commitment to semiconductor leadership, with strong federal involvement and meaningful dialogue around talent development and acquisition—an encouraging signal for companies like Edgewater as we scale our team and impact. About Edgewater Wireless We make Wi-Fi. Better. Edgewater Wireless is redefining Wi-Fi from the silicon up—delivering standards-leading innovations that create strategic value for next-generation connectivity platforms and semiconductor licensing partners. With 26 granted patents and a fabless business model, Edgewater Wireless pioneered Wi-Fi Spectrum Slicing, a breakthrough technology purpose built to address the surging global demand for higher-capacity, lower-latency wireless networks. Edgewater is supercharging the economics of Wi-Fi. At a time when incremental performance gains are no longer enough, Spectrum Slicing offers a transformative leap: enabling multiple concurrent channels within a single frequency band. The result— 10x or greater performance and 50% lower latency—benefits all devices, including legacy hardware, without requiring changes to the client side. This architecture delivers scalable, infrastructure-friendly gains across residential, enterprise, and IoT environments. Our technology is deeply aligned with the evolving standards and shaped by collaboration with Tier-one service providers, enterprises and industry bodies. For more information about Edgewater Wireless and its innovative Wi-Fi solutions, visit Forward-Looking Statements This news release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. The use of any of the words "expect", "anticipate", "continue", "estimate", "objective", "ongoing", "may", "will", "project", "should", "believe", "plans", "intends" and similar expressions are intended to identify forward-looking information or statements. Although Edgewater Wireless believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forward-looking statements and information because Edgewater Wireless can give no assurance that they will prove to be correct. By its nature, such forward-looking information is subject to various risks and uncertainties, which could cause Edgewater Wireless' actual results and experience to differ materially from the anticipated results or expectations expressed. These risks and uncertainties, include, but are not limited to access to capital markets, market forces, competition from new and existing companies and regulatory conditions. Readers are cautioned not to place undue reliance on this forward-looking information, which is given as of the date it is expressed in this news release or otherwise, and to not use future-oriented information or financial outlooks for anything other than their intended purpose. Edgewater Wireless undertakes no obligation to update publicly or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by law.

NioBay Announces the Start of Its 2025 Drill Campaign on Its Crevier Project
NioBay Announces the Start of Its 2025 Drill Campaign on Its Crevier Project

Yahoo

time41 minutes ago

  • Yahoo

NioBay Announces the Start of Its 2025 Drill Campaign on Its Crevier Project

MONTRÉAL, June 10, 2025 (GLOBE NEWSWIRE) -- NioBay Metals Inc. ('NioBay' or the 'Company') (TSX-V: NBY) (OTCQB: NBYCF) is pleased to announce the start of a drilling campaign on the Crevier property (the '2025 Campaign'), located approximately 50 km north of the town of Girardville and approximately 150 km from the Niobec mine (the 'Project'). It is located within the Nitassinan territory of the Pekuakamiulnuatsh, whose main population center is Mashteuiatsh. The Project is easily accessible via existing logging roads. The 2025 Campaign is made possible by a grant from the Ministère des Ressources naturelles et des Forêts (MRNF) under the Mining Exploration Support Program for Critical and Strategic Minerals. The drilling will be large in diameter (HQ) in order to collect a maximum quantity of material. Bulk sampling is also planned and will be combined with the drill core collected to produce a sample of more than 125 metric tons, representative of the extension zones. Figure 1: Location of 2025 drill holesNioBay is pleased to announce that this campaign will be carried out by the Premières Nations drilling company in Mashteuiatsh. Geological supervision has been entrusted to the Saguenay firm IOS Services Géoscientifiques. It should be noted that the latter was also involved in previous drilling campaigns on this site. Message from NioBay's President and Chief Executive Officer on Crevier 'This campaign will allow us to recover more material than during the 2023 campaign. In addition, this work will allow us to test the extensions of the known zone. Building on our first pilot plant, this campaign prepares us for our next pilot plant, which will be ten times larger than the first. We will use this second pilot plant to manufacture more product for our potential customers. Once again, we are pleased to carry out this work with the support of a local labor force, such as Forage Premières Nations of Mashteuiatsh and IOS Services Géoscientifiques of Chicoutimi,' says Jean-Sébastien David, President and CEO. Qualified Person This press release has been reviewed and approved by Jean-Sébastien David, a qualified person under National Instrument 43-101. Mr. David is President and Chief Executive Officer of NioBay. About NioBay Metals Inc. NioBay aims to become a leader in the development of mine(s) with low carbon consumption and responsible water and wildlife management practices while prioritizing the environment, social responsibility, good governance, and the inclusion of all stakeholders. Our top priority, which is critical to our success, is the consent and full participation of the Indigenous communities in whose territories and/or on ancestral lands we operate. In addition to others properties, NioBay holds a 100% interest in the James Bay Niobium Project located 45 km south of Moosonee, in the Moose Cree Traditional Territory of the James Bay Lowlands in Ontario. NioBay also holds a 72.5% interest in the Crevier Niobium and Tantalum project located in Québec and on the Nitassinan territory of the Pekuakaminulnuatsh First Nation. The Company has also the option to acquire a 80% interest in the Foothills project, a titanium-phosphate project located near the former St-Urbain mine site in Québec. About Niobium Niobium is a naturally occurring element. It is a metal that is ductile, malleable and highly resistant to corrosion. Because it enhances properties and functionalities, niobium is used in a wide range of materials and applications in the Mobility, Structural and Energy sectors. Niobium transforms materials. When added to materials like steel, glass and aluminum castings, niobium makes them more efficient and lowers environmental impacts, while also increased value. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accept responsibility for the adequacy or accuracy of this release. Cautionary Statement Certain statements contained in this press release constitute forward-looking information under the provisions of Canadian securities laws including statements about the Company's plans. Such statements are necessarily based upon a number of beliefs, assumptions, and opinions of management on the date the statements are made and are subject to numerous risks and uncertainties that could cause actual results and future events to differ materially from those anticipated or projected. The Company undertakes no obligation to update these forward-looking statements in the event that management's beliefs, estimates or opinions, or other factors should change, except as required by law. FOR MORE INFORMATION, CONTACT: NioBay Metals David, & Chief Executive OfficerTel.: 514 866-6500jsdavid@ Kimberly Darlington Investor Relations kimberly@ Tel: 514-771-3398 A photo accompanying this announcement is available at in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Unicycive Provides Update on New Drug Application for Oxylanthanum Carbonate to Treat Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis
Unicycive Provides Update on New Drug Application for Oxylanthanum Carbonate to Treat Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis

Yahoo

timean hour ago

  • Yahoo

Unicycive Provides Update on New Drug Application for Oxylanthanum Carbonate to Treat Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis

- The U.S. Food and Drug Administration (FDA) identified deficiencies at a third-party manufacturing vendor - FDA to provide final decision by PDUFA action date of June 28, 2025 LOS ALTOS, Calif., June 10, 2025 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY or the 'Company'), a clinical-stage biotechnology company developing therapies for patients with kidney disease, today announced an update on its New Drug Application (NDA) for oxylanthanum carbonate (OLC) to treat hyperphosphatemia in patients with chronic kidney disease (CKD) on dialysis. The FDA communicated to the Company that it had identified deficiencies in cGMP compliance at a third-party manufacturing vendor (one of its CDMO's third-party subcontractors and not its Drug Substance vendor) following an FDA inspection. The FDA indicated that, given the identified deficiencies, any label discussions between the FDA and the Company are precluded. The Company has responded to all FDA information requests and expects a final decision from the FDA by the PDUFA action date of June 28, 2025. 'We are discussing with our partners to help resolve FDA's concerns and remain confident in the promise of OLC based on the extensive clinical and preclinical data we've generated,' said Shalabh Gupta, M.D., Chief Executive Officer of Unicycive. 'We believe OLC is a promising new treatment option and we are eager to bring it as quickly as we can to patients with CKD on dialysis who are living with hyperphosphatemia.' About Oxylanthanum Carbonate (OLC)OLC is an investigational oral phosphate binder that leverages proprietary nanoparticle technology to deliver high phosphate binding potency, reducing the number and size of pills that patients must take to treat hyperphosphatemia in patients with chronic kidney disease (CKD) on dialysis. Its potential best-in-class profile may have meaningful patient adherence benefits over currently available treatment options as it requires a lower pill burden. Unicycive is seeking FDA approval of OLC via the 505(b)(2) regulatory pathway. The NDA submission package is based on data from three clinical studies (a Phase 1 study in healthy volunteers, a bioequivalence study in healthy volunteers, and a tolerability study of OLC in CKD patients on dialysis), multiple preclinical studies, and the chemistry, manufacturing and controls (CMC) data. OLC is protected by a strong global patent portfolio including issued patents on composition of matter with exclusivity until 2031, and with the potential for patent term extension until 2035. About HyperphosphatemiaHyperphosphatemia is a serious medical condition that occurs in nearly all patients with End Stage Renal Disease (ESRD). Annually there are over 450,000 individuals in the U.S. that require medication to control their phosphate levels.2 Uncontrolled hyperphosphatemia is strongly associated with increased death and hospitalization for CKD patients on dialysis. Treatment of hyperphosphatemia is aimed at lowering serum phosphate levels via two means: (1) restricting dietary phosphorus intake; and (2) using, on a daily basis, and with each meal, oral phosphate binding drugs that facilitate fecal elimination of dietary phosphate rather than its absorption from the gastrointestinal tract into the bloodstream. About Unicycive TherapeuticsUnicycive Therapeutics is a biotechnology company developing novel treatments for kidney diseases. Unicycive's lead investigational treatment is oxylanthanum carbonate, a novel phosphate binding agent currently under review by the U.S. Food and Drug Administration (FDA) for the treatment of hyperphosphatemia in patients with chronic kidney disease who are on dialysis. Unicycive's second investigational treatment UNI-494 is intended for the treatment of conditions related to acute kidney injury. It has been granted orphan drug designation (ODD) by the FDA for the prevention of Delayed Graft Function (DGF) in kidney transplant patients and has completed a Phase 1 dose-ranging safety study in healthy volunteers. For more information, please visit and follow us on LinkedIn and X. Forward-looking statements Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified using words such as "anticipate," "believe," "forecast," "estimated" and "intend" or other similar terms or expressions that concern Unicycive's expectations, strategy, plans or intentions. These forward-looking statements are based on Unicycive's current expectations and actual results could differ materially. There are several factors that could cause actual events to differ materially from those indicated by such forward-looking statements. These factors include, but are not limited to, clinical trials involve a lengthy and expensive process with an uncertain outcome, and results of earlier studies and trials may not be predictive of future trial results; our clinical trials may be suspended or discontinued due to unexpected side effects or other safety risks that could preclude approval of our product candidates; risks related to business interruptions, which could seriously harm our financial condition and increase our costs and expenses; dependence on key personnel; substantial competition; uncertainties of patent protection and litigation; dependence upon third parties; and risks related to failure to obtain FDA clearances or approvals and noncompliance with FDA regulations. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including: the uncertainties related to market conditions and other factors described more fully in the section entitled 'Risk Factors' in Unicycive's Annual Report on Form 10-K for the year ended December 31, 2024, and other periodic reports filed with the Securities and Exchange Commission. Any forward-looking statements contained in this press release speak only as of the date hereof, and Unicycive specifically disclaims any obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise.1 Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol. 2004 Aug;15(8):2208-18. doi: 10.1097/ PMID: 15284307.2 Flythe JE. Dialysis-Past, Present, and Future: A Kidney360 Perspectives Series. Kidney360. 2023 May 1;4(5):567-568. doi: 10.34067/KID.0000000000000145. Epub 2023 Jun 29. PMID: 37229723; PMCID: PMC10371371. Investor Contact:Kevin GardnerLifeSci Advisorskgardner@ Contact:Rachel Visi Real Chemistryredery@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store